Dr. Camille Bedrosian resigns from Rhythm Pharmaceuticals board

RHYTHM PHARMACEUTICALS, INC.

Camille L. Bedrosian, M.D. resigned from the Board effective December 16, 2025.
She served on the Compensation & Management Development and Governance and Nominating Committees.
Resignation not due to any disagreement with the Company or its operations, policies, or practices.

item 5.02

RHYTHM PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-25-123108

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.